device for the treatment of aortic valve regurgitation after promising results in a 2-year initial study. If this novel option performs as well as surgical aortic valve replacement (SAVR ...

Background: Surgical aortic valve replacement (SAVR) is the preferred treatment option for patients with severe aortic regurgitation (AR). Recently, several patients with mixed aortic valve disease, ...

Background: Fragility of the ascending aortic wall has been reported in patients with aortic regurgitation (AR), thought to be affected by turbulence in the ascending aorta. However, the mechanism ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, showcased 2-year follow up data from the ALIGN-AR Trial at TCT 2024. Concurrently, the ...

JenaValve announced today that it received the green light to begin a new randomized controlled trial for its Trilogy device.

"US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024" was originally created and ...

Surgical aortic valve replacement (sAVR) is known to result in transient perioperative deterioration ... such as balloon valvuloplasty, acute aortic regurgitation and temporary hypotension during ...

Zoom in or out of the page as needed for optimal reading comfort. You can also use a pinch gesture to zoom on touch devices.

A new software program that uses artificial intelligence to read echocardiograms may reduce the wait times for results and ...

Ischemic cardiomyopathy changes how the heart pumps blood because of muscle damage. Learn about the role of medication in ...

Authors of a recent review shared expert insights and tips for conducting cardiac catheterization procedures to diagnose ...

Valve has announced the Steam Deck OLED: White Edition. This new version of the handheld PC launches on 18th November, but if you want one, be warned: only a limited number will be available ...